EVOXAC ORAL SOLUTION
"EVOXAC ORAL SOLUTION" is a word and design mark owned by Cosette Pharmaceuticals, Inc., filed at the USPTO on August 19, 2025. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since April 29, 2026
- Filed
- August 19, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99345341
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 1 class
Who owns EVOXAC ORAL SOLUTION
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Cosette Pharmaceuticals, Inc.
Bridgewater, United States
Representative
Mark A. Mazza
Eckert Seamans Cherin & Mellott, LLC
What the mark covers
The products and services EVOXAC ORAL SOLUTION is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of Sjogren's syndrome and/or Xerosis
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 1 granted
- Sou extension 1 filed
- Sou teas extension received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Examiner's amendment entered
8 earlier steps on the official record.
About EVOXAC ORAL SOLUTION
Who owns the trademark "EVOXAC ORAL SOLUTION"?
The USPTO trademark "EVOXAC ORAL SOLUTION" (application 99345341) is owned by Cosette Pharmaceuticals, Inc.
What is the status of "EVOXAC ORAL SOLUTION"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull EVOXAC ORAL SOLUTION and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b14-0436-726d-b16e-a05149033158
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b14-0436-726d-b16e-a05149033158",
"object": "trademark",
"mark_text": "EVOXAC ORAL SOLUTION",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99345341",
"filing_date": "2025-08-19",
"nice_classes": [
5
],
"owners": [
{
"name": "Cosette Pharmaceuticals, Inc.",
"entity_id": "ent_019ee990-717b-701a-93db-f9bccda411bf"
}
]
}